Performance analysis of Achilles Therapeutics (ACHL)
Annual Return
Over the past 3 years, ACHL has had an average annual return of +10.07%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, ACHL has had an average annual return of -25.74%, underperforming the benchmark SPY, which returned +12.55% annual.
Since Mar 31, 2021, ACHL has had an average annual return of -36.56%, underperforming the benchmark SPY, which returned +14.06% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | +29.75% | +28.31% | -1.29% | -82.03% | -69.73% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | ||||||
| 2025 | -0.87% | +22.11% | +7.19% | +29.75% | |||||||||
| 2024 | +4.66% | +41.99% | -5.39% | -40.00% | +22.74% | -11.51% | +1.83% | -13.17% | +41.61% | -1.95% | +7.62% | +6% | +28.31% |
| 2023 | +37.68% | -11.21% | -12.93% | -13.30% | +20.32% | -5.46% | +7.88% | -8.77% | -2.14% | -5.45% | -4.04% | +7.62% | -1.29% |
| 2022 | -24.15% | -12.89% | -11.20% | -24.49% | +12.68% | +0.79% | +1.18% | +14.08% | -22.30% | -14.64% | +4.72% | -55.45% | -82.03% |
| 2021 | +0% | -6.04% | -18.78% | -22.49% | -40.44% | +16.29% | +14.89% | -21.18% | -16.93% | -1.78% | -69.73% |
Drawdown analysis of Achilles Therapeutics (ACHL)
The maximum drawdown for the ACHL was -96.08%, occurring on Sep 11, 2024. This drawdown has not yet recovered.
The current ACHL drawdown is -91.72%.
Since Mar 31, 2021 ACHL has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.08% | Apr 6, 2021 | 864 | Sep 11, 2024 | Ongoing | Ongoing | Ongoing |
| -9.85% | Mar 31, 2021 | 2 | Apr 5, 2021 | 1 | Apr 6, 2021 | 3 |